Gujarat Terce Laboratories Limited (GUJTERC.BO)
INR 58.61
(-4.17%)
INR 58.61
(-4.17%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 161.67 Million INR | -26.04% |
| 2022 | 218.6 Million INR | 14.9% |
| 2021 | 190.25 Million INR | 34.53% |
| 2020 | 141.41 Million INR | 24.1% |
| 2019 | 113.95 Million INR | 32.21% |
| 2018 | 86.19 Million INR | -5.38% |
| 2017 | 91.09 Million INR | -33.01% |
| 2016 | 135.98 Million INR | -3.82% |
| 2015 | 141.37 Million INR | -7.41% |
| 2014 | 152.69 Million INR | 1.9% |
| 2013 | 149.83 Million INR | 1.7% |
| 2012 | 147.33 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q4 | - INR | -100.0% |
| 2023 Q1 | 218.6 Million INR | 0.0% |
| 2023 Q2 | - INR | -100.0% |
| 2023 Q3 | 195.71 Million INR | 0.0% |
| 2023 FY | 161.67 Million INR | -26.04% |
| 2022 Q4 | - INR | -100.0% |
| 2022 FY | 218.6 Million INR | 14.9% |
| 2022 Q1 | 190.25 Million INR | 0.0% |
| 2022 Q2 | - INR | -100.0% |
| 2022 Q3 | 215.04 Million INR | 0.0% |
| 2021 Q1 | 141.41 Million INR | 0.0% |
| 2021 FY | 190.25 Million INR | 34.53% |
| 2021 Q2 | - INR | -100.0% |
| 2021 Q3 | 155.2 Million INR | 0.0% |
| 2021 Q4 | - INR | -100.0% |
| 2020 FY | 141.41 Million INR | 24.1% |
| 2020 Q4 | - INR | -100.0% |
| 2020 Q3 | 116.87 Million INR | 0.0% |
| 2020 Q2 | - INR | -100.0% |
| 2020 Q1 | 113.95 Million INR | 0.0% |
| 2019 Q2 | - INR | -100.0% |
| 2019 Q1 | 85.02 Million INR | 0.0% |
| 2019 FY | 113.95 Million INR | 32.21% |
| 2019 Q4 | - INR | -100.0% |
| 2019 Q3 | 110.17 Million INR | 0.0% |
| 2018 Q2 | - INR | -100.0% |
| 2018 Q1 | 90.63 Million INR | 0.0% |
| 2018 FY | 86.19 Million INR | -5.38% |
| 2018 Q3 | 108.24 Million INR | 0.0% |
| 2018 Q4 | - INR | -100.0% |
| 2017 FY | 91.09 Million INR | -33.01% |
| 2017 Q1 | 135.98 Million INR | 0.0% |
| 2017 Q2 | - INR | -100.0% |
| 2017 Q3 | 86.34 Million INR | 0.0% |
| 2016 Q3 | 142.26 Million INR | 0.0% |
| 2016 Q1 | 141.1 Million INR | 0.0% |
| 2016 Q4 | - INR | -100.0% |
| 2016 FY | 135.98 Million INR | -3.82% |
| 2015 Q1 | 152.69 Million INR | 0.0% |
| 2015 FY | 141.37 Million INR | -7.41% |
| 2015 Q4 | - INR | -100.0% |
| 2015 Q2 | - INR | -100.0% |
| 2015 Q3 | 145.48 Million INR | 0.0% |
| 2014 Q3 | 87.63 Million INR | 0.0% |
| 2014 Q4 | - INR | -100.0% |
| 2014 FY | 152.69 Million INR | 1.9% |
| 2014 Q1 | 149.83 Million INR | 0.0% |
| 2014 Q2 | - INR | -100.0% |
| 2013 Q1 | 146.6 Million INR | 0.0% |
| 2013 FY | 149.83 Million INR | 1.7% |
| 2013 Q2 | - INR | -100.0% |
| 2013 Q4 | - INR | -100.0% |
| 2013 Q3 | 166.44 Million INR | 0.0% |
| 2012 FY | 147.33 Million INR | 0.0% |
| 2012 Q3 | 279.46 Million INR | 0.0% |
| 2010 Q1 | 74.73 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| ANG Lifesciences India Limited | 1.66 Billion INR | 90.27% |
| Add-Shop E-Retail Limited | 159.2 Million INR | -1.551% |
| Bacil Pharma Limited | 1.12 Million INR | -14220.106% |
| BDH Industries Limited | 312.53 Million INR | 48.27% |
| Beryl Drugs Limited | 85.63 Million INR | -88.792% |
| Cian Healthcare Limited | 1.03 Billion INR | 84.37% |
| Chemo Pharma Laboratories Limited | 2.12 Million INR | -7497.462% |
| Concord Drugs Limited | 249.88 Million INR | 35.301% |
| Deccan Health Care Limited | 111.33 Million INR | -45.213% |
| DECIPHER LABS LIMITED | 117.72 Million INR | -37.332% |
| Gujarat Themis Biosyn Limited | 197.37 Million INR | 18.087% |
| Hindustan Bio Sciences Limited | 25.7 Million INR | -529.056% |
| Jenburkt Pharmaceuticals Limited | 201.59 Million INR | 19.801% |
| Ishita Drugs and Industries Limited | 8.87 Million INR | -1722.295% |
| Kwality Pharmaceuticals Limited | 1.71 Billion INR | 90.58% |
| Panchsheel Organics Limited | 340.2 Million INR | 52.477% |
| KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | 83.773% |
| Parnax Lab Limited | 1.17 Billion INR | 86.19% |
| Makers Laboratories Limited | 569.18 Million INR | 71.595% |
| Medi-Caps Limited | 63.01 Million INR | -156.56% |
| MedPlus Health Services Limited | 14.27 Billion INR | 98.867% |
| Phaarmasia Limited | 211.49 Million INR | 23.557% |
| Parmax Pharma Limited | 117.56 Million INR | -37.516% |
| Patidar Buildcon Limited | 25.57 Million INR | -532.231% |
| Sanjivani Paranteral Limited. | 155.06 Million INR | -4.262% |
| SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -53971.572% |
| Trident Lifeline Limited | 331.26 Million INR | 51.195% |
| Tyche Industries Limited | 101.64 Million INR | -59.064% |
| Vivanza Biosciences Limited | 148.63 Million INR | -8.775% |
| PRAVEG LIMITED | 767.53 Million INR | 78.936% |
| Smruthi Organics Limited | 485.72 Million INR | 66.715% |
| Source Natural Foods and Herbal Supplements Limited | 41.97 Million INR | -285.195% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | 90.568% |
| Sastasundar Ventures Limited | 1.5 Billion INR | 89.226% |
| Transchem Limited | 6.72 Million INR | -2305.863% |
| Trinity League India Limited | 876 Thousand INR | -18355.936% |
| Vikram Thermo (India) Limited | 291.47 Million INR | 44.533% |
| Vista Pharmaceuticals Limited | 175.16 Million INR | 7.703% |
| Sunil Healthcare Limited | 902.83 Million INR | 82.093% |
| Syschem (India) Limited | 1.07 Billion INR | 84.9% |
| Zenith Healthcare Limited | 24.03 Million INR | -572.661% |
| Zenlabs Ethica Limited | 301.35 Million INR | 46.351% |
| Mercury Laboratories Limited | 171.18 Million INR | 5.558% |
| SHELTER PHARMA LIMITED | 20.99 Million INR | -670.243% |
| Vasundhara Rasayans Limited | 53.64 Million INR | -201.366% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1 Billion INR | 83.902% |
| Roopa Industries Limited | 493.08 Million INR | 67.212% |
| PANJON LTD. | 25.38 Million INR | -536.938% |
| Pharmaids Pharmaceuticals Limited | 208.44 Million INR | 22.437% |
| TIAAN CONSUMER LIMITED | 14.97 Million INR | -979.338% |
| Anuh Pharma Limited | 1.54 Billion INR | 89.533% |
| Crestchem Limited | 23.94 Million INR | -575.133% |
| Emmessar Biotech & Nutrition Limited | 13.4 Million INR | -1106.072% |
| Sandu Pharmaceuticals Limited | 118.22 Million INR | -36.753% |
| Fredun Pharmaceuticals Limited | 1.86 Billion INR | 91.314% |
| Trimurthi Limited | 101.36 Thousand INR | -159404.736% |
| Shukra Pharmaceuticals Limited | 201.97 Million INR | 19.953% |
| Norris Medicines Limited | 278.17 Million INR | 41.88% |
| Veerhealth Care Limited | 62.78 Million INR | -157.525% |
| Lactose (India) Limited | 536.39 Million INR | 69.859% |
| OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | 80.595% |
| Ambalal Sarabhai Enterprises Limited | 1.13 Billion INR | 85.704% |
| Gennex Laboratories Limited | 535.21 Million INR | 69.793% |
| Denis Chem Lab Limited | 289.82 Million INR | 44.216% |
| Colinz Laboratories Limited | 24.1 Million INR | -570.707% |
| Godavari Drugs Limited | 957.86 Million INR | 83.121% |
| Zenotech Laboratories Limited | 156.64 Million INR | -3.208% |
| Shree Ganesh Remedies Limited | 488.36 Million INR | 66.895% |
| Bharat Parenterals Limited | 2.65 Billion INR | 93.914% |
| Coral Laboratories Limited | 281.83 Million INR | 42.636% |
| Evoq Remedies Limited | 116.23 Million INR | -39.096% |
| Kerala Ayurveda Limited | 1.05 Billion INR | 84.714% |
| KOBO BIOTECH LIMITED | 2.04 Billion INR | 92.087% |
| Natural Capsules Limited | 1.47 Billion INR | 89.055% |
| Auro Laboratories Limited | 433.09 Million INR | 62.67% |